Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension

被引:0
|
作者
Ahmed Elgebaly
Bassant Abdelazeim
Omar Mattar
Mohamed Gadelkarim
Rehab Salah
Ahmed Negida
机构
[1] Al Azhar University,Faculty of Medicine
[2] Cairo University,Medical Research Society
[3] Cairo University,Kasr Al Ainy School of Medicine
[4] Alexandria University,Faculty of Medicine
[5] Medical Research Group of Egypt,Faculty of Medicine
[6] Benha University,Faculty of Medicine
[7] Zagazig University,Student Research Unit
[8] TICO-Zagazig University,undefined
来源
关键词
Droxidopa; Orthostatic hypotension; Dizziness; Pure autonomic failure; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:171 / 180
页数:9
相关论文
共 50 条
  • [21] Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hewitt, L. Arthur
    Ziemann, Adam
    Biaggioni, Italo
    Cherny, Katya
    Vernino, Steven
    NEUROLOGY, 2017, 88
  • [22] Predictors of response to droxidopa in patients with neurogenic orthostatic hypotension
    Palma, Jose-Alberto
    Martinez, Jose
    Perez, Miguel
    Kaufmann, Horacio
    NEUROLOGY, 2017, 88
  • [23] Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hewitt, L. A.
    Biaggioni, I.
    Ziemann, A.
    Vernino, S.
    MOVEMENT DISORDERS, 2017, 32 (09) : E8 - E8
  • [24] Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases
    Perez-Lloret, Santiago
    Quarracino, Cecilia
    Otero-Losada, Matilde
    Rascol, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (06) : 635 - 645
  • [25] Persistence of Droxidopa Treatment in Patients With Neurogenic Orthostatic Hypotension
    Basile, J.
    Kymes, S.
    Jackson, K.
    Widolff, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S241 - S241
  • [26] Neurogenic orthostatic hypotension - management update and role of droxidopa
    Vijayan, Joy
    Sharma, Vijay K.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 915 - 923
  • [27] Analysis of efficacy in patients with symptomatic neurogenic orthostatic hypotension treated with droxidopa and dopa-decarboxylase inhibitors
    Biaggioni, I.
    Low, P.
    Rowse, G.
    Kaufmann, H.
    MOVEMENT DISORDERS, 2012, 27 : S422 - S423
  • [28] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Francois, Clement
    Rowse, Gerald J.
    Hewitt, L. Arthur
    Vo, Pamela
    Hauser, Robert A.
    BMC NEUROLOGY, 2016, 16
  • [29] Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hauser, Robert A.
    Biaggioni, Italo
    Hewitt, L. Arthur
    Vernino, Steven
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (06): : 627 - 634
  • [30] Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension
    Clément François
    Gerald J. Rowse
    L. Arthur Hewitt
    Pamela Vo
    Robert A. Hauser
    BMC Neurology, 16